The FDA granted a new use for diabetes drug Farxiga (dapagliflozin): to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and established heart disease or risk factors for it.
from WebMD Health https://www.webmd.com/diabetes/news/20191021/fda-oks-diabetes-drug-for-type-2-heart-failure-risk?src=RSS_PUBLIC
0 Comments:
Post a Comment